+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Central Nervous System Disorder Drugs Companies in China

  • PDF Icon

    Report

  • 48 Pages
  • November 2023
  • Region: China
  • AMID Co
  • ID: 3453750

China's demand for Central Nervous System Disorder Drugs will continue to grow at 12% by 2032

This study focuses on China’s Central Nervous System Disorder Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumptions of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market.

Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.

This new study analyzes the industry structure, capacities and output. Major producers' production locations, market shares and profiles are presented. The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and the in-house databases.

Table of Contents

I. INTRODUCTION
  • Report Scope and Methodology
  • Executive Summary
III. CENTRAL NERVOUS SYSTEM DISORDER DRUGS INDUSTRY ASSESSMENTS
  • Central Nervous System Disorder Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Central Nervous System Disorder Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producers’ Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development
VII. CENTRAL NERVOUS SYSTEM DISORDER DRUGS PRODUCER DIRECTORY
  • Profiles of Central Nervous System Disorder Drugs Producers
LIST OF TABLES
I. INTRODUCTION
  • Economic Outlook Summary
III. CENTRAL NERVOUS SYSTEM DISORDER DRUGS INDUSTRY ASSESSMENTS
  • Top 10 Central Nervous System Disorder Drugs Sales Volume and Market Share
  • Central Nervous System Disorder Drugs Sales Volume
  • Major Producer Facility Location
  • Major Central Nervous System Disorder Drugs Producer Sales Volume
  • Major Foreign Investment in China
LIST OF CHARTS
I. INTRODUCTION
  • Central Nervous System Disorder Drugs Sales Volume
II. CENTRAL NERVOUS SYSTEM DISORDER DRUGS INDUSTRY ASSESSMENTS
  • Central Nervous System Disorder Drugs Sales Volume
  • Central Nervous System Disorder Drugs Market Share by Drugs Classification
  • Top 10 Central Nervous System Disorder Drugs Market Share
  • Central Nervous System Disorder Drugs Sales Volume

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AstraZeneca China
  • Lilly Pharmaceutical China Inc